title: Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
authors.affiliation: Department of Surgery, Notre-Dame Hospital, Montreal, Québec, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Smeesters
authors.forename: P
authors.initials: P
authors.lastname: Chaland
authors.forename: L
authors.initials: L
authors.lastname: Giroux
authors.forename: J M
authors.initials: JM
authors.lastname: Moutquin
authors.forename: P
authors.initials: P
authors.lastname: Etienne
authors.forename: F
authors.initials: F
authors.lastname: Douglas
authors.forename: J
authors.initials: J
authors.lastname: Corman
authors.forename: G
authors.initials: G
authors.lastname: St-Louis
authors.forename: P
authors.initials: P
authors.lastname: Daloze
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000652:urine; D000818:Animals; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000037:antagonists & inhibitors / Q000633:toxicity*; D015232:Dinoprostone; D007674:Kidney Diseases / Q000139:chemically induced*; D008297:Male; D011458:Prostaglandins E / Q000652:urine; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D013929:Thromboxane B2 / Q000652:urine; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors
chemical_list: D003524:Cyclosporins; D011458:Prostaglandins E; D011725:Pyridines; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; C049113:3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid; D003404:Creatinine; D013930:Thromboxane-A Synthase; D015232:Dinoprostone